Page last updated: 2024-08-05 11:18:29
chlorobenzoic acid
Any member of the class of benzoic acids in which the benzene ring is substituted by at least one chloro group.
ChEBI ID: 23134
Members (10)
Member | Definition | Role |
---|---|---|
2,4-dichloro-5-(2-furanylmethylsulfamoyl)benzoic acid | 2,4-dichloro-5-(2-furanylmethylsulfamoyl)benzoic acid | |
2,4-dichlorobenzoic acid | A chlorobenzoic acid that is benzoic acid in which the ring hydrogens at positions 2 and 4 are substituted by chloro groups. | 2,4-dichlorobenzoic acid |
2,5-dichlorobenzoic acid | A chlorobenzoic acid that is benzoic acid in which the ring hydrogens at positions 2 and 5 are substituted by chloro groups. | 2,5-dichlorobenzoic acid |
2,6-dichlorobenzoic acid | A chlorobenzoic acid carrying two chloro groups at positions 2 and 6 respectively. | 2,6-dichlorobenzoic acid |
3,4-dichlorobenzoic acid | A chlorobenzoic acid carrying chloro substituents at positions 3 and 4. | 3,4-dichlorobenzoic acid |
3,5-dichlorosalicylic acid | 3,5-Dichlorosalicylicacid | |
4,5-dichloro-2-[oxo-(8-quinolinylamino)methyl]benzoic acid | 4,5-dichloro-2-[oxo-(8-quinolinylamino)methyl]benzoic acid | |
5-chlorosalicylic acid | A monohydroxybenzoic acid that is 2-hydroxybenzoic acid (salicylic acid) in which the hydrogen at position 5 is replaced by chlorine. | 5-chlorosalicylic acid |
amiben | Chloramben | |
furosemide | A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure. | furosemide |
Research
Studies (12,854)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 6,115 (47.57) | 18.7374 |
1990's | 2,166 (16.85) | 18.2507 |
2000's | 1,859 (14.46) | 29.6817 |
2010's | 2,022 (15.73) | 24.3611 |
2020's | 692 (5.38) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 1,358 (9.89%) | 5.53% |
Reviews | 649 (4.72%) | 6.00% |
Case Studies | 1,308 (9.52%) | 4.05% |
Observational | 49 (0.36%) | 0.25% |
Other | 10,372 (75.51%) | 84.16% |